Biesert L - Search Results

1

Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.

Biesert L, Suhartono H. Biesert L, et al. Vox Sang. 1998;74 Suppl 1:207-12. doi: 10.1111/j.1423-0410.1998.tb05474.x. Vox Sang. 1998. PMID: 9789530 Review.

2

Viral safety of a new highly purified factor VIII (OCTATE).

Biesert L, Lemon S, Goudeau A, Suhartono H, Wang L, Brede HD. Biesert L, et al. J Med Virol. 1996 Apr;48(4):360-6. doi: 10.1002/(SICI)1096-9071(199604)48:4<360::AID-JMV10>3.0.CO;2-F. J Med Virol. 1996. PMID: 8699169

3

Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate).

Stadler M, Gruber G, Kannicht C, Biesert L, Radomski KU, Suhartono H, Pock K, Neisser-Svae A, Weinberger J, Römisch J, Svae TE. Stadler M, et al. Among authors: biesert l. Biologicals. 2006 Dec;34(4):281-8. doi: 10.1016/j.biologicals.2005.11.010. Epub 2006 Feb 23. Biologicals. 2006. PMID: 16500114

4

Virus validation experiments on the production process of OCTAVI SDPlus.

Biesert L, Lemon S, Suhartono H, Wang L, Rübsamen H. Biesert L, et al. Blood Coagul Fibrinolysis. 1995 Jul;6 Suppl 2:S48-54. doi: 10.1097/00001721-199506002-00011. Blood Coagul Fibrinolysis. 1995. PMID: 7495968

5

Anti-human immunodeficiency virus (HIV) drug HOE/BAY946 increases membrane hydrophobicity of human lymphocytes and specifically suppresses HIV-protein synthesis.

Biesert L, Adamski M, Zimmer G, Suhartono H, Fuchs J, Unkelbach U, Mehlhorn RJ, Hideg K, Milbradt R, Rübsamen-Waigmann H. Biesert L, et al. Med Microbiol Immunol. 1990;179(6):307-21. doi: 10.1007/BF00189609. Med Microbiol Immunol. 1990. PMID: 1965549

6

Markers for HIV-disease progression in untreated patients and patients receiving AZT: evaluation of viral activity, AZT resistance, serum cholesterol, beta 2-microglobulin, CD4+ cell counts, and HIV antigen.

Rübsamen-Waigmann H, Schröder B, Biesert L, Bauermeister CD, von Briesen H, Suhartono H, Zimmermann F, Brede HD, Regeniter A, Gerte S, et al. Rübsamen-Waigmann H, et al. Among authors: biesert l. Infection. 1991;19 Suppl 2:S77-82. doi: 10.1007/BF01644472. Infection. 1991. PMID: 1673119

7

Inhibition of HIV and virus replication by polysulphated polyxylan: HOE/BAY 946, a new antiviral compound.

Biesert L, Suhartono H, Winkler I, Meichsner C, Helsberg M, Hewlett G, Klimetzek V, Mölling K, Schlumberger HD, Schrinner E, et al. Biesert L, et al. AIDS. 1988 Dec;2(6):449-57. doi: 10.1097/00002030-198812000-00007. AIDS. 1988. PMID: 2468349

8

Synthesis and bioactivity studies of 1-adamantanamine derivatives of peptides.

Horvat S, Varga-Defterdarović L, Horvat J, Jukić R, Kantoci D, Chung NN, Schiller PW, Biesert L, Pfützner A, Suhartono H, et al. Horvat S, et al. Among authors: biesert l. J Pept Sci. 1995 Sep-Oct;1(5):303-10. doi: 10.1002/psc.310010505. J Pept Sci. 1995. PMID: 9223009

9

Biochemical and genetical analysis of AZT-resistant HIV-mutants.

Biesert L, Zimmermann F, Schröder B, Matthes E, Suhartono H, Dietrich U, Rübsamen-Waigmann H. Biesert L, et al. Behring Inst Mitt. 1991 Jul;(89):74-80. Behring Inst Mitt. 1991. PMID: 1930105

10

Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.

Dichtelmüller HO, Biesert L, Fabbrizzi F, Gajardo R, Gröner A, von Hoegen I, Jorquera JI, Kempf C, Kreil TR, Pifat D, Osheroff W, Poelsler G. Dichtelmüller HO, et al. Among authors: biesert l. Transfusion. 2009 Sep;49(9):1931-43. doi: 10.1111/j.1537-2995.2009.02222.x. Epub 2009 May 20. Transfusion. 2009. PMID: 19497061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page